M. Brooke Bernhardt

1.5k total citations · 1 hit paper
68 papers, 934 citations indexed

About

M. Brooke Bernhardt is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, M. Brooke Bernhardt has authored 68 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pediatrics, Perinatology and Child Health, 36 papers in Public Health, Environmental and Occupational Health and 15 papers in Oncology. Recurrent topics in M. Brooke Bernhardt's work include Acute Lymphoblastic Leukemia research (33 papers), Childhood Cancer Survivors' Quality of Life (30 papers) and Pharmaceutical studies and practices (14 papers). M. Brooke Bernhardt is often cited by papers focused on Acute Lymphoblastic Leukemia research (33 papers), Childhood Cancer Survivors' Quality of Life (30 papers) and Pharmaceutical studies and practices (14 papers). M. Brooke Bernhardt collaborates with scholars based in United States, Canada and Germany. M. Brooke Bernhardt's co-authors include Eric S. Schafer, James A. Whitlock, Elizabeth A. Raetz, Mignon L. Loh, Stephanie Terezakis, Michael J. Borowitz, Lia Gore, Laura Hogan, Gerhard Zugmaier and Elad Sharon and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

M. Brooke Bernhardt

65 papers receiving 911 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia

2021 207 citations Patrick A. Brown, Lingyun Ji et al. profile →

Peers

M. Brooke Bernhardt

PHEOH

PPCH

ONCOL

HEMAT

Adam Gassas Canada

Catherine Cole Australia

Ketan Kulkarni Canada

Bernard L. Marini United States

E. Le Gall France

H.-U. Meier-Kriesche United States

Dimitrios Koliouskas Greece

C. C. Bailey United Kingdom

J. Jeffrey Malatack United States

Alka Khadwal India

Adam Gassas Canada

M. Brooke Bernhardt

235 ×0.6

PHEOH

206 ×0.7

PPCH

238 ×0.8

ONCOL

460 ×2.8

HEMAT

124 ×1.1

Citations per year, relative to M. Brooke Bernhardt M. Brooke Bernhardt (= 1×) peers Adam Gassas

Countries citing papers authored by M. Brooke Bernhardt

Since Specialization

Citations

This map shows the geographic impact of M. Brooke Bernhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Brooke Bernhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Brooke Bernhardt more than expected).

Fields of papers citing papers by M. Brooke Bernhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Brooke Bernhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Brooke Bernhardt. The network helps show where M. Brooke Bernhardt may publish in the future.

Co-authorship network of co-authors of M. Brooke Bernhardt

This figure shows the co-authorship network connecting the top 25 collaborators of M. Brooke Bernhardt. A scholar is included among the top collaborators of M. Brooke Bernhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Brooke Bernhardt. M. Brooke Bernhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, Tamara P., Ethan A. Poweleit, Austin L. Brown, et al.. (2025). What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High‐Dose Methotrexate Use in Pediatric Malignancies. Pediatric Blood & Cancer. 72(7). e31744–e31744. 1 indexed citations

Bernhardt, M. Brooke, et al.. (2025). Advancing non-sterile pediatric pharmacotherapy through automated compounding and 3D printing of ondansetron hcl dihydrate dosage forms. Journal of Oncology Pharmacy Practice. 32(1). 71–86.

DeGroote, Nicholas P., Holly Lindsay, Eric S. Schafer, et al.. (2024). Toxicity profile of high‐dose methotrexate in young children with central nervous system tumors. Pediatric Blood & Cancer. 71(10). e31213–e31213.

Hogan, Laura, Patrick A. Brown, Lingyun Ji, et al.. (2023). Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse. Journal of Clinical Oncology. 41(25). 4118–4129. 33 indexed citations

Bernhardt, M. Brooke, et al.. (2023). Novel and replicated clinical and genetic risk factors for toxicity from high‐dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(3). 205–214. 8 indexed citations

Militano, Olga, et al.. (2023). Methotrexate Scarcity Among Children’s Oncology Group Institutions: Results of a Multinational Survey. The Oncologist. 30(8). 4 indexed citations

Bernhardt, M. Brooke, et al.. (2023). Impact of undernutrition on the pharmacokinetics of chemotherapy in children with cancer: A systematic review. Pediatric Blood & Cancer. 70(9). e30531–e30531. 6 indexed citations

Swartz, Michael D., M. Brooke Bernhardt, Han Chen, et al.. (2022). Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia. Leukemia & lymphoma. 63(12). 2948–2954. 5 indexed citations

Bruno, Michael A., et al.. (2022). Distribution and frequency of tyrosine kinase inhibitor‐associated long‐term complications in children with chronic myeloid leukemia. Pediatric Blood & Cancer. 69(9). e29786–e29786. 2 indexed citations

10.

Schraw, Jeremy M., M. Brooke Bernhardt, Olga A. Taylor, et al.. (2021). Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia. Scientific Reports. 11(1). 19613–19613. 10 indexed citations

11.

Whittle, Sarah Burkhead, Valeria Smith, Allison Silverstein, et al.. (2020). Is high‐risk neuroblastoma induction chemotherapy possible without G‐CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatric Blood & Cancer. 67(10). e28417–e28417. 3 indexed citations

12.

Bernhardt, M. Brooke, et al.. (2020). Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage. Pediatric Blood & Cancer. 67(9). e28334–e28334. 7 indexed citations

13.

Adamson, Peter C., Gareth J. Veal, Richard B. Womer, et al.. (2019). Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear‐medicine‐based estimates of renal function. Pediatric Blood & Cancer. 66(6). e27672–e27672. 5 indexed citations

14.

Schafer, Eric S., et al.. (2019). Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL). Leukemia & lymphoma. 61(5). 1246–1249. 8 indexed citations

15.

Bernhardt, M. Brooke, et al.. (2019). The Effect of Topical Vancomycin Treatment against Sternal Wound Infection in Patients Undergoing Coronary Artery Bypass Graft Surgery. The Thoracic and Cardiovascular Surgeon. 1 indexed citations

16.

Foster, Jennifer H., Patrick A. Thompson, M. Brooke Bernhardt, et al.. (2018). A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities. Cancer Chemotherapy and Pharmacology. 83(2). 349–360. 16 indexed citations

17.

Brackett, Julienne, et al.. (2017). Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification. Cancer Chemotherapy and Pharmacology. 80(6). 1261–1264. 10 indexed citations

18.

Unguru, Yoram, Conrad V. Fernandez, M. Brooke Bernhardt, et al.. (2016). An Ethical Framework for Allocating Scarce Life-Saving Chemotherapy and Supportive Care Drugs for Childhood Cancer. JNCI Journal of the National Cancer Institute. 108(6). djv392–djv392. 25 indexed citations

19.

Brackett, Julienne, Eric S. Schafer, Daniel H. Leung, & M. Brooke Bernhardt. (2013). Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism. Pediatric Blood & Cancer. 61(6). 1114–1117. 26 indexed citations

20.

Raphael, Jean L., M. Brooke Bernhardt, Donald H. Mahoney, & Brigitta U. Mueller. (2009). Oral iron chelation and the treatment of iron overload in a pediatric hematology center. Pediatric Blood & Cancer. 52(5). 616–620. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact